New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells
Authors:
- Rosaria OttanàRosaria Ottanà
- Rosanna MaccariRMRosanna Maccari
- Simona AmusoSASimona Amuso
- Gerhard WolberGWGerhard Wolber
- Daniela SchusterDSDaniela Schuster
- Sonja HerdlingerSHSonja Herdlinger
- Giampaolo ManaoGMGiampaolo Manao
- Guido CamiciGCGuido Camici
- Paolo PaoliPaolo Paoli
- 1 April 2012
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 50, 332-343
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Elevated Hypothalamic TCPTP in Obesity Contributes to Cellular Leptin ResistanceCell Metabolism, 2011
- T-Cell Protein Tyrosine Phosphatase Attenuates STAT3 and Insulin Signaling in the Liver to Regulate GluconeogenesisDiabetes, 2010
- Inhibition of Protein Tyrosine Phosphatase-1B with Antisense Oligonucleotides Improves Insulin Sensitivity and Increases Adiponectin Concentrations in MonkeysEndocrinology, 2009
- Protein tyrosine phosphatase function: the substrate perspectiveBiochemical Journal, 2007
- Protein tyrosine phosphatases: from genes, to function, to diseaseNature Reviews Molecular Cell Biology, 2006
- Protein-tyrosine phosphatases and cancerNature Reviews Cancer, 2006
- The Protein Data BankNucleic Acids Research, 2000
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- Molecular recognition of receptor sites using a genetic algorithm with a description of desolvationJournal of Molecular Biology, 1995
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970